managing patient dose in msct

76
John Damilakis, PhD Assist. Professor of Medical Physics University of Crete, Iraklion, Crete, Greece [email protected] Managing patient dose in MSCT

Upload: doantruc

Post on 04-Feb-2017

229 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Managing patient dose in MSCT

John Damilakis, PhDAssist. Professor of Medical Physics

University of Crete, Iraklion, Crete, [email protected]

Managing patient dose in MSCT

Page 2: Managing patient dose in MSCT

Aim

• Are the doses from a MSCT examination high?

• What are the radiation risks?

• How can we manage patient dose?

• Are the doses from a MSCT examination high?

Page 3: Managing patient dose in MSCT

Patient sample (n = 250)

18-28

Age group (years)

10 %

30 %

28-38 38-48 48-58 58-68 68-78 >78

20 %

Page 4: Managing patient dose in MSCT

Scans per patient

1 2 3 4 5 6 7

Patie

nt f

ract

ion

(%)

Number of scans

10

40

Page 5: Managing patient dose in MSCT

Scans per anatomic region

0.5

1

1.5

2

# o

f sc

ans

HEAD THORAX LUMBAR ABDOMEN LOWERSPINE ABDOMEN

Page 6: Managing patient dose in MSCT

Mean number of scans per patientN

o o

f sc

ans

per

patie

nt

2.5

0.5

1.5

Males Females

Total

Contrast

Page 7: Managing patient dose in MSCT

Anatomic regions scannedPa

tient

fra

ctio

n (%

)

Number of anatomic regions scanned

10

70

60

50

1 2 3 4

Page 8: Managing patient dose in MSCT

Effective dose per scan and anatomic region

3

6

9

12

mSv

HEAD THORAX LUMBAR ABDOMEN UPPERSPINE ABDOMEN

Page 9: Managing patient dose in MSCT

Mean effective dose per patient

per scanper patient

mSv

15

3

9

Males Females

Page 10: Managing patient dose in MSCT

Are CT doses comparable to background radiation ?

Average background dose :

3 mSv / year (chronic exposure)

Average CT dose :

14 mSv / examination (acute exposure)

Page 11: Managing patient dose in MSCT

Normalized effective dose vs. age

Medical Physics (in press)

Nor

mal

ized

dos

e

Patient age

Head - neck

0 2 4 6 8 10 12 14 16 18

150

140

130

120

110

100

90

Nor

mal

ized

dos

e

Patient age0 2 4 6 8 10 12 14 16 18

450

400

350

300

250

200

150

Chest

Nor

mal

ized

dos

ePatient age

0 2 4 6 8 10 12 14 16 18

950

880

810

740

670

600

530

Trunk

Nor

mal

ized

dos

e

Patient age

0 2 4 6 8 10 12 14 16 18

750

680

610

540

470

400

330

Abdomen - Pelvis

Page 12: Managing patient dose in MSCT

Normalized effective dose vs age

5 y

580 µSv/mGy

5-year-old Abdominal scan

120 kV, 35 mAs, BC = 24 mm, pitch = 1, rsw = 5.0 mm

ED = ND x CTDI = 580 x 6.4 = 3.7 mSv

Nor

mal

ized

eff

ectiv

e d

ose

(µSv

/ mG

y)

0 2 4 6 8 10 12 14 16 18

750

680

610

540

470

400

330

Patient age (y)

Page 13: Managing patient dose in MSCT

Effective dose per scan from pediatric MSCT (abdomen)

2 4 6 8 10 12 14 16 18

20

4

12mSv

8

16

Patient Age (years)

Page 14: Managing patient dose in MSCT

Effective dose per scan from pediatric CT (head & neck / trunk)

mSv

2 4 6 8 10 12 14 16 18

20

4

12

8

16

Patient Age (yr)

head

trunk

Page 15: Managing patient dose in MSCT

Thyroid doses from head & neck CT

0 5 10 15

0.4

0.3

0.2

0.1

0.0Nor

mal

ized

th

yroi

d

dose

Brain

0 5 10 15

0.4

0.3

0.2

0.1

0.0Nor

mal

ized

th

yroi

d

dose

Paranasal sinuses

0 5 10 15

0.08

0.06

0.04

0.02

0.00Nor

mal

ized

th

yroi

d

dose

Inner ear

Patient Age

0 5 10 15

1.50

1.45

1.40

1.35

1.30Nor

mal

ized

th

yroi

d

dose

Neck

Patient Age

European Radiology, 2006 Sep 21; [Epub ahead of print]

Page 16: Managing patient dose in MSCT

Thyroid dose per scan from pediatric head and neck MSCT

Neck, spiral

Brain, spiralBrain, seq

Dos

e m

Gy

50

10

30

20

40

2 4 6 8 10 12 14 16 18Patient Age (yr)

Page 17: Managing patient dose in MSCT

Aim

• Are the doses from a MSCT examination high?

• What are the radiation risks?

• How can we manage patient dose?

• Are the doses from a MSCT examination high?

• What are the radiation risks?

Page 18: Managing patient dose in MSCT

Biological effects of radiation

Deterministic effects :

Stochastic effects :

As dose increases, the probability of the effect

occurring increases.

Stochastic effects are assumed to have no threshold.

They are characterized by a threshold dose, below

which the effect does not occur.

Carcinogenesis

Opacities

Page 19: Managing patient dose in MSCT

SourceSource : BEIR V: BEIR V

Risk coefficients for fatal cancer

Age at acute exposure (yr)

Ris

k p

er U

nit

Dos

e (%

per

Sv)

10 20 30 40 50 60 70 80

3

6

9

12

15 5-year-old

Dose from an abdominal scan: 3.7 mSv

5 y

13.5 % per Sv

Risk = 13.5 x 3.7 x 10-3 % = 0.05 %

Page 20: Managing patient dose in MSCT

Risk of radiation-induced fatal cancer from MSCT (abdomen)

Est

imat

ed R

isk

(%)

10 20 30 40 50 60 70 80 Age at acute exposure (yr)

0.25

0.05

0.15

0.10

0.20

0.30

Page 21: Managing patient dose in MSCT

The probability of radiogenic risk for cancer is not negligible

The number of CT examinations is increasing worldwide

Variety of examinations is increasing

3.6

33

1980 1998 2007 Year

Numberof CTexaminations(millions)

?

Page 22: Managing patient dose in MSCT

Aim

• Are the doses from a MSCT examination high?

• What are the risks?

• How can we manage patient dose?

• Are the doses from a MSCT examination high?

• What are the risks?

• How can we manage patient dose?

Page 23: Managing patient dose in MSCT

How can we manage patient dose?

Proper selection of scanning parameters

Use of technologic innovations

Protection of radiosensitive organs

Justification

Page 24: Managing patient dose in MSCT

Justification

BENEFITS

RISKS

Page 25: Managing patient dose in MSCT

Justification

RISKS

BENEFITS

Page 26: Managing patient dose in MSCT

How do we know if CT is the mostappropriate examination ?

An ACR committee has developed criteria for determining

appropriate imaging examinations for diagnosis and

treatment of specified medical conditions.

These criteria are intended to guide radiologists, radiation

oncologists, and referring physicians in making decisions

regarding radiologic imaging and treatment.

Page 27: Managing patient dose in MSCT

www.acr.org

Page 28: Managing patient dose in MSCT

How can we manage patient dose?

Proper selection of scanning parameters

Use of technologic innovations

Protection of radiosensitive organs

Justification

Page 29: Managing patient dose in MSCT

Parameters that affect CT dose

kV, mAs

Filtration

Beam shaping filter Collimation

Detection system efficiency

Scanning length, Reconstruction slice width, Pitch, Scanner geometry, Algorithms

Page 30: Managing patient dose in MSCT

A comprehensive evaluation of the dosimetric characteristics

of a CT scanner is needed.

Some years ago, we used to follow rules for an optimized

CT dose reduction in patients.

A dose-effective use of any scanner can only be established

with on-site measurements of its dosimetric characteristics.

Page 31: Managing patient dose in MSCT

Rotation Time

Page 32: Managing patient dose in MSCT

Do we optimize a MSCT examination by

selecting short or long rotation time ?

Rotation time decreased

A: The shortest rotation time should be selected to

minimize motion artifacts.

mA increased

Page 33: Managing patient dose in MSCT

mA & automatic change from small to large focal spot

European Radiology, 16:2575-85, 2006

nCTD

Iw (

mG

y/10

0 m

As)

7.5

8.5

9.5

10.5

0 100 200 300 400 500Tube current (mA)

210

Page 34: Managing patient dose in MSCT

When a high tube load is required, an increased

rotation time should be preferred in order to

avoid the automatic selection of the large focal

spot.

Do we optimize a MSCT examination by

selecting short or long rotation time ?

Page 35: Managing patient dose in MSCT

Pitch

Page 36: Managing patient dose in MSCT

mAseff =mAs

pitch

Do we optimize a MSCT examination by

selecting high or low pitch value ?

A: Higher pitch is associated with a reduced dose to the

patient because of a shorter exposure time.

Page 37: Managing patient dose in MSCT

European Radiology, 16:2575-85, 2006

CTD

Iv (

mG

y)

60

65

70

75

0.2 0.4 0.6 0.8 1.0 1.2Pitch

High or low pitch value ?

mAseff =mAs

pitch

Page 38: Managing patient dose in MSCT

Medical Physics 32:1621-1629, 2005

z-overscanning

z-overscanning

In spiral CT, the tissue volume

of patient irradiated differs

from the volume imaged.

z – overscanning (overranging)

Page 39: Managing patient dose in MSCT

BC = 16 x 1.5

Ove

rsca

nnin

g

25

50

75

100

0 2 4 6 8 10RSW (mm)

z – overscanning (mm)

Pitch = 0.5

Pitch = 1.0

Pitch = 1.5

Medical Physics, 32:1621-1629, 2005

Page 40: Managing patient dose in MSCT

BC = 16 x 0.75

Ove

rsca

nnin

g

25

50

75

100

0 2 4 6 8 10RSW (mm)

z – overscanning (mm)

Pitch = 0.5Pitch = 1.0

Pitch = 1.5

Medical Physics, 32:1621-1629, 2005

Page 41: Managing patient dose in MSCT

van der Molen, A. J. et al. Radiology 2006;0:2421051350

z - overscanning

Page 42: Managing patient dose in MSCT

van der Molen, A. J. et al. Radiology 2006;0:2421051350

z - overscanning

Page 43: Managing patient dose in MSCT

z - overscanning

When radiosensitive organs are marginally included in

the examination field, proper selection of BC, RSW and

pitch is needed to restrict z - overscanning.

The relative contribution of the extra exposure due to

z–overscanning may be considerable especially when the

planned image volume is limited.

Page 44: Managing patient dose in MSCT

z - overscanning

Thick beam collimation (24 mm) increases patient

dose due to z-overscanning.

For a given beam collimation, an increase in

the RSW increases patient dose. High pitch

values increase dose due to z-overscanning.

Page 45: Managing patient dose in MSCT

High pitch values increase dose due to:

• automatic selection of focal spot size

• z-overscanning

Do we optimize a MSCT examination by

selecting high or low pitch value ?

Page 46: Managing patient dose in MSCT

Beam Collimation

Page 47: Managing patient dose in MSCT

Do we optimize a MSCT examination by

selecting wide or narrow beam collimation ?

A: The wider the beam the smaller the percentage of

wasted radiation due to overbeaming. Therefore, we

optimize a MSCT examination by selecting wide

collimation.

Page 48: Managing patient dose in MSCT

z axis

Overbeaming

wasted radiation

=

Overbeaming

z axis

Page 49: Managing patient dose in MSCT

Overbeaming

However, wide collimation limits the width of the thinnest sections

that can be reconstructed.

The wider the beam the smaller the percentage of wasted radiation.

Page 50: Managing patient dose in MSCT

Beam Collimation

Scans at thick BC’s are to be preferred on the

basis of protecting the patient from radiation.

Narrow collimations should be avoided as they

are less dose effective, unless their use is dictated

by the clinical need for thin reconstructed slices.

Page 51: Managing patient dose in MSCT

16 x 1.5

DOSE

OVERSCANNING OVERBEAMING

DOSE OVERBEAMING OVERSCANNING

16 x 0.75

Thick beam collimation (24 mm) increases patient dose due to overscanning

Beam Collimation

Page 52: Managing patient dose in MSCT

• Head examinations: 16 x 1.5 mm

Recommended beam configuration

for Siemens Sensation 16:

Medical Physics, in press

• Body examinations: 16 x 0.75 mm

16 x 1.5

16 x 0.75

Page 53: Managing patient dose in MSCT

Do we optimize a CT examination by selecting

wide or narrow beam collimation ?

• Head examinations: 16 x 1.5 mm

• Body examinations: 16 x 0.75 mm

Overbeaming and z - overscanning are two

competing effects regarding patient radiation

burden.

Page 54: Managing patient dose in MSCT

Motion artifacts can be avoided by selecting:

• short rotation time

What is the proper selection of scanning

parameters to avoid motion artifacts ?

However, the dose to the patient increases !

• high pitch value

• wide beam collimation

However, the dose to the patient increases !However, the dose to the patient increases !

Page 55: Managing patient dose in MSCT

‘Standard’ rules to reduce dose

• Scan minimal length

• Reduce mAs without compromising image quality

Efforts must be made to

restrict the scan length to

that clinically essential.

• Reduce number of multiple scans

Page 56: Managing patient dose in MSCT

How can we manage patient dose?

Proper selection of scanning parameters

Use of technologic innovations

Protection of radiosensitive organs

Justification

Page 57: Managing patient dose in MSCT

a

b

mA modulation: Performance evaluation

aOR =

b

Submitted for publication

Page 58: Managing patient dose in MSCT

mA modulation

Oval ratio

Anatomic position (mm)

0 150 300 450 600 750 900

2.5

2

1.5

1

0.5

Ova

l ra

tio

% Dose Reduction

- 10- 50510152025303540

% D

ose

Red

uctio

n

Page 59: Managing patient dose in MSCT

10-year-oldO

val

ratio

% D

ose

Red

uctio

n

Anatomic position (mm)

5-year-old

1-year-old

neonate

Page 60: Managing patient dose in MSCT

Helical Mode 16x1.5 Sequential Mode 12x1.5

mA modulation

Page 61: Managing patient dose in MSCT

mA modulation

The dose reduction achieved with tube mA modulation

is not substantial for neonates and young children.

mA-modulation should be considered as a complementary

means to reduce dose and should not replace other

dose reduction methods, especially in young children.

Page 62: Managing patient dose in MSCT

Software tools for noise simulation

What is the effect of a possible reduction of mA on image quality?

By courtesy of IMP, Erlangen

Page 63: Managing patient dose in MSCT

Software tools for noise simulation

By courtesy of IMP, Erlangen

Page 64: Managing patient dose in MSCT

How can we manage patient dose?

Proper selection of scanning parameters

Use of technologic innovations

Protection of radiosensitive organs

Justification

Page 65: Managing patient dose in MSCT

Bismuth

shielding

Eur Radiol 16:2334-2340, 2006

Page 66: Managing patient dose in MSCT

The threshold for ophthalmologically detectable opacities

has been reported to be 0.5–1.3 Gy. These values refer to

adult individuals and therefore may be lower in infants.

ICRP 60, 1990 & NRPB Vol 7, Nr 3, 1996

Dose to the eye lens per scan: 0.07 Gy in CT scanning

of sinuses and 0.13 Gy in CT of orbital trauma.

NCRP Publication 87, 2000

Eye lens dose from pediatric CT

Page 67: Managing patient dose in MSCT

Εye bismuth shielding

Medical Physics 32, 1024-1030, 2005

Dose reduction factors (%) of eye lens dose

CT examination Infants 1 year 5 years 10 years 15 years

Scanning of orbits 33.1 35.7 37.4 37.1 35.2

Scanning of the head 31.4 32.8 33.1 34.7 33.0

Angled scan. excl. orbits < 1 <1 <1 <1 <1

Page 68: Managing patient dose in MSCT

A considerable reduction in eye lens dose may be

achieved by using orbital bismuth shielding during

pediatric head CT scans. However, this shielding

should not be used in children when the eyes are

excluded from the primarily exposed region.

Protection of radiosensitive organsEye Shielding

Page 69: Managing patient dose in MSCT

z – overscanning and eye lens dose

Medical Physics, 33:2472-2478, 2006

In helical mode, the proximity of eye lenses to the

boundaries of planned image volume in combination

with the additional exposure due to z-overscanning,

can result in a significant increase in the lens dose.

Page 70: Managing patient dose in MSCT

z – overscanning and paediatric patients

-1 0 1 2 3

Nor

mal

ized

eye

len

s do

se (

mG

y/m

Gy)

Distance from first scan line (cm)

0.5

1.0

1.5

2.0

axial scanning

helical, pitch = 1

helical, pitch = 0.5

Medical Physics, 33:2472-2478, 2006

Page 71: Managing patient dose in MSCT

What is the distance of eye lens from thefirst slice of the volume to be imaged ?

2745Total

33IV (distance = 2 to 3 cm)

69III (distance = 1 to 2cm)

1221II ( distance = 0 to 1cm)

612I (distance = -1 to 0 cm)

Number of helical examinations

Number of axial examinations

Category

Medical Physics, 33:2472-2478, 2006

II ( distance = 0 to 1cm) 21 12

Page 72: Managing patient dose in MSCT

z – overscanning and paediatric patients

It is more dose efficient to use axial mode acquisition

rather than helical scan for pediatric head studies, if

there are no overriding clinical considerations.

Protection of radiosensitive organs

Page 73: Managing patient dose in MSCT

Messages to take home

Radiation dose from MSCT examinations is not

comparable to background radiation.

The probability of radiogenic risk for cancer

from MSCT examinations is not negligible.

Page 74: Managing patient dose in MSCT

Messages to take home

A dose-effective use of a MSCT scanner can

only be established with on-site measurements

of its dosimetric characteristics.

The relative contribution of the extra exposure

due to z-overscanning may be considerable.

Page 75: Managing patient dose in MSCT

Messages to take home‘Standard rules’ can be used to reduce dose

Justify CT examinations

Scan minimal length

Reduce mAs without compromizing quality

Reduce number of multiple scans

Avoid radiosensitive organs

Page 76: Managing patient dose in MSCT

HANDOUTS:

URL ADDRESS: http://medicalphysics.med.uoc.gr/handouts/